검색어: enżimatika (몰타어 - 영어)

fabrazyme hu terapija enżimatika sostituttiva.
fabrazyme is an enzyme replacement therapy.

Żieda fl-attività enżimatika tal-fwied
increases in liver enzyme activity

id-determinazzjoni tal-glukożju għandha ssir permezz tar-rotta enżimatika.
the glucose determination is performed by the enzymatic route.

proteina miksuba b'idroliżi enżimatika kkontrollata tal-proteini tal-patata.
protein obtained by a controlled enzymatic hydrolysis of potato proteins.

clofarabine mhuwiex metabolizzat b’mod li jingħaraf bis-sistema enżimatika cytochrome p450 (cyp).
clofarabine is not detectably metabolised by the cytochrome p450 (cyp) enzyme system.

prodott miksub bl-idroliżi enżimatika ta’ krill sħiħ jew partijiet tiegħu ħafna drabi konċentrat bit-tnixxif.
product obtained by the enzymatic hydrolysis of whole or parts of krill often concentrated by drying.

sa awwissu 2007, inbnew erba’ impjanti ta’ idroliżi enżimatika, u ġew ordnati ħamsa oħra madwar ir-renju unit.
by august 2007, four enzymic hydrolysis plants had been built, and five more ordered around the uk.

il-metaboliti huma biċċiet żgħar ta' peptidi ffurmati wara l-idrolosi enżimatika fuq il-ganirelix f’ siti ristretti.
the metabolites are small peptide fragments formed by enzymatic hydrolysis of ganirelix at restricted sites.

wara injezzjoni iv jew im, parecoxib huwa malajr mibdul għal valdecoxib, is-sustanza farmakoloġikament attiva, b’idroliżi enżimatika fil-fwied.
following iv or im injection, parecoxib is rapidly converted to valdecoxib, the pharmacologically active substance, by enzymatic hydrolysis in the liver.

kejl kwantitattiv tal-ħalib xkumat tat-trab fl-għalf kompost permezz tal-koagulazzjoni enżimatika tal-para-każeina.
quantitative determination of skimmed-milk powder in compound feedingstuffs by enzymatic coagulation of para-casein.

fabrazyme jingħata bħala terapija ta ’ sostituzzjoni ta ’ enżimi fil- marda fabry, meta l- livell ta ’ l- attività enżimatika ta ’ α- galactosidase hija nieqsa jew inqas min- normal.
fabrazyme is used as enzyme replacement therapy in fabry disease, where the level of α - galactosidase enzyme activity is absent or lower than normal.